
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | $388.3M | $389.6M | $390.2M | |
Revenue Growth (YoY) | -- | -- | -- | 0.33% | 0.16% | |
Cost of Revenues | -- | -- | $59.8M | $66.4M | $79.3M | |
Gross Profit | -- | -- | $328.6M | $323.2M | $310.9M | |
Gross Profit Margin | -- | -- | 84.61% | 82.95% | 79.68% | |
R&D Expenses | -- | -- | $46.8M | $52.2M | $63.8M | |
Selling, General & Admin | -- | -- | $209.7M | $243.4M | $254.8M | |
Other Inc / (Exp) | -- | -- | -$4.3M | -$2.8M | $2.4M | |
Operating Expenses | -- | -- | $260M | $300.2M | $325.3M | |
Operating Income | -- | -- | $68.6M | $23M | -$14.4M | |
Net Interest Expenses | -- | -- | -- | -- | $122.8K | |
EBT. Incl. Unusual Items | -- | -- | $65.7M | $20.2M | -$12.1M | |
Earnings of Discontinued Ops. | -- | -- | $16.6M | $1.8M | $2.7M | |
Income Tax Expense | -- | -- | $32.2M | $16.1M | $13.8M | |
Net Income to Company | -- | -- | $50.1M | $5.8M | -$23.2M | |
Minority Interest in Earnings | -- | -- | -- | $247.3K | $488.5K | |
Net Income to Common Excl Extra Items | -- | -- | $50.1M | $6.1M | -$22.7M | |
Basic EPS (Cont. Ops) | -- | -- | -$0.00 | -$0.73 | -$1.13 | |
Diluted EPS (Cont. Ops) | -- | -- | -$0.00 | -$0.73 | -$1.13 | |
Weighted Average Basic Share | -- | -- | $459.4M | $459.4M | $459.4M | |
Weighted Average Diluted Share | -- | -- | $459.4M | $459.4M | $459.4M | |
EBITDA | -- | -- | $72.1M | $27.7M | -$5.3M | |
EBIT | -- | -- | $68.6M | $23M | -$11.9M | |
Revenue (Reported) | -- | -- | $388.3M | $389.6M | $390.2M | |
Operating Income (Reported) | -- | -- | $68.6M | $23M | -$14.4M | |
Operating Income (Adjusted) | -- | -- | $68.6M | $23M | -$11.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | $104.3M | $88.9M | $117.4M | |
Revenue Growth (YoY) | -- | -- | -- | -14.76% | 31.97% | |
Cost of Revenues | -- | -- | $16.7M | $17.9M | $23.2M | |
Gross Profit | -- | -- | $87.6M | $71M | $94.1M | |
Gross Profit Margin | -- | -- | 84% | 79.84% | 80.2% | |
R&D Expenses | -- | -- | $13.5M | $14.9M | $16.9M | |
Selling, General & Admin | -- | -- | $60.6M | $65.9M | $56.6M | |
Other Inc / (Exp) | -- | -- | -$3.6M | -$26.5K | -$1.1M | |
Operating Expenses | -- | -- | $75.7M | $80.8M | $73.5M | |
Operating Income | -- | -- | $11.9M | -$9.8M | $20.6M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -- | -- | $8.4M | -$9.8M | $19.5M | |
Earnings of Discontinued Ops. | -- | -- | $885.8K | -- | -- | |
Income Tax Expense | -- | -- | $6.2M | $2.7M | $6.6M | |
Net Income to Company | -- | -- | $3.1M | -$12.6M | -- | |
Minority Interest in Earnings | -- | -- | $52.4K | $121.8K | $146.7K | |
Net Income to Common Excl Extra Items | -- | -- | $3.1M | -$12.4M | $13.1M | |
Basic EPS (Cont. Ops) | -- | -- | $0.25 | -$2.39 | -$0.02 | |
Diluted EPS (Cont. Ops) | -- | -- | $0.25 | -$2.39 | -$0.02 | |
Weighted Average Basic Share | -- | -- | $459.4M | $459.4M | $461.5M | |
Weighted Average Diluted Share | -- | -- | $459.4M | $459.4M | $461.5M | |
EBITDA | -- | -- | $13.5M | -$8.9M | $20.6M | |
EBIT | -- | -- | $11.9M | -$9.8M | $20.6M | |
Revenue (Reported) | -- | -- | $104.3M | $88.9M | $117.4M | |
Operating Income (Reported) | -- | -- | $11.9M | -$9.8M | $20.6M | |
Operating Income (Adjusted) | -- | -- | $11.9M | -$9.8M | $20.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | $374.2M | $417.6M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | $67.7M | $84.6M | |
Gross Profit | -- | -- | -- | $306.6M | $333M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | $53.5M | $65.9M | |
Selling, General & Admin | -- | -- | -- | $247.7M | $245.1M | |
Other Inc / (Exp) | -- | -- | -$3.6M | $740K | $1.4M | |
Operating Expenses | -- | -- | -- | $305.3M | $316.9M | |
Operating Income | -- | -- | -- | $1.2M | $16M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -- | -- | -- | $2M | $17.3M | |
Earnings of Discontinued Ops. | -- | -- | $885.7K | $898.7K | $2.7M | |
Income Tax Expense | -- | -- | -- | $12.7M | $17.7M | |
Net Income to Company | -- | -- | -- | -$9.8M | -- | |
Minority Interest in Earnings | -- | -- | $52.4K | $316.7K | $513.4K | |
Net Income to Common Excl Extra Items | -- | -- | -- | -$9.5M | $2.8M | |
Basic EPS (Cont. Ops) | -- | -- | -- | -$3.37 | $1.25 | |
Diluted EPS (Cont. Ops) | -- | -- | -- | -$3.37 | $1.25 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -- | -- | -- | $6.3M | $24.4M | |
EBIT | -- | -- | -- | $1.2M | $18.5M | |
Revenue (Reported) | -- | -- | -- | $374.2M | $417.6M | |
Operating Income (Reported) | -- | -- | -- | $1.2M | $16M | |
Operating Income (Adjusted) | -- | -- | -- | $1.2M | $18.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | $104.3M | $88.9M | $117.4M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | $16.7M | $17.9M | $23.2M | |
Gross Profit | -- | -- | $87.6M | $71M | $94.1M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | $13.5M | $14.9M | $16.9M | |
Selling, General & Admin | -- | -- | $60.6M | $65.9M | $56.6M | |
Other Inc / (Exp) | -- | -- | -$3.6M | -$26.5K | -$1.1M | |
Operating Expenses | -- | -- | $75.7M | $80.8M | $73.5M | |
Operating Income | -- | -- | $11.9M | -$9.8M | $20.6M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -- | -- | $8.4M | -$9.8M | $19.5M | |
Earnings of Discontinued Ops. | -- | -- | $885.8K | -- | -- | |
Income Tax Expense | -- | -- | $6.2M | $2.7M | $6.6M | |
Net Income to Company | -- | -- | $3.1M | -$12.6M | -- | |
Minority Interest in Earnings | -- | -- | $52.4K | $121.8K | $146.7K | |
Net Income to Common Excl Extra Items | -- | -- | $3.1M | -$12.4M | $13.1M | |
Basic EPS (Cont. Ops) | -- | -- | $0.25 | -$2.39 | -$0.02 | |
Diluted EPS (Cont. Ops) | -- | -- | $0.25 | -$2.39 | -$0.02 | |
Weighted Average Basic Share | -- | -- | $459.4M | $459.4M | $461.5M | |
Weighted Average Diluted Share | -- | -- | $459.4M | $459.4M | $461.5M | |
EBITDA | -- | -- | $13.5M | -$8.9M | $20.6M | |
EBIT | -- | -- | $11.9M | -$9.8M | $20.6M | |
Revenue (Reported) | -- | -- | $104.3M | $88.9M | $117.4M | |
Operating Income (Reported) | -- | -- | $11.9M | -$9.8M | $20.6M | |
Operating Income (Adjusted) | -- | -- | $11.9M | -$9.8M | $20.6M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | -- | -- | $436.2M | $372.3M | $270.7M | |
Short Term Investments | -- | -- | $485.9K | $45.5M | $108.3M | |
Accounts Receivable, Net | -- | -- | $19.2M | $15.6M | $304.9M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | $26.9M | $36.2M | $8.1M | |
Other Current Assets | -- | -- | $1.1M | $3M | $5.2M | |
Total Current Assets | -- | -- | $1B | $1.2B | $1.9B | |
Property Plant And Equipment | -- | -- | $44.4M | $46.2M | $99.9M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | $5.2M | $5.2M | |
Other Intangibles | -- | -- | $18M | $21.4M | $19.4M | |
Other Long-Term Assets | -- | -- | $90 | $19.3K | -- | |
Total Assets | -- | -- | $1.1B | $1.3B | $2.1B | |
Accounts Payable | -- | -- | $82.9M | $640.2M | $1.4B | |
Accrued Expenses | -- | -- | $24.1M | $7.8M | $12M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | $2.5M | $3.5M | $5M | |
Other Current Liabilities | -- | -- | $428M | $4.2M | $9.2M | |
Total Current Liabilities | -- | -- | $563.1M | $680.5M | $1.4B | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | -- | -- | $578.2M | $695.9M | $1.5B | |
Common Stock | -- | -- | $2B | $2.3B | $2.9B | |
Other Common Equity Adj | -- | -- | -$8.5M | -$6.9M | -$15.2M | |
Common Equity | -- | -- | -$1.5B | -$1.8B | -$2.3B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | $660.2K | $1.3M | |
Total Equity | -- | -- | $513.5M | $564.3M | $606.8M | |
Total Liabilities and Equity | -- | -- | $1.1B | $1.3B | $2.1B | |
Cash and Short Terms | -- | -- | $436.7M | $417.9M | $379M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | -- | -- | -- | $388.7M | $297.5M | |
Short Term Investments | -- | -- | -- | $59.4M | $105.8M | |
Accounts Receivable, Net | -- | -- | -- | $88.1M | $299.8M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | -- | -- | -- | $77M | $61.3M | |
Total Current Assets | -- | -- | -- | $1.3B | $1.9B | |
Property Plant And Equipment | -- | -- | -- | $45.1M | $97.8M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | $5.2M | $5.2M | |
Other Intangibles | -- | -- | -- | $20.2M | $19.9M | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | -- | -- | -- | $1.4B | $2B | |
Accounts Payable | -- | -- | -- | $744.4M | $1.3B | |
Accrued Expenses | -- | -- | -- | $47.5M | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | $3.2M | $3.4M | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | -- | -- | -- | $795.4M | $1.4B | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | -- | -- | -- | $809.7M | $1.4B | |
Common Stock | -- | -- | -- | $3.5B | $2.9B | |
Other Common Equity Adj | -- | -- | -- | -$9.6M | -$13.4M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | $40.3M | -- | |
Minority Interest, Total | -- | -- | -- | $528K | $1.1M | |
Total Equity | -- | -- | -- | $601.4M | $629.5M | |
Total Liabilities and Equity | -- | -- | -- | $1.4B | $2B | |
Cash and Short Terms | -- | -- | -- | $448.2M | $403.3M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | $50.1M | $5.8M | -$23.2M | |
Depreciation & Amoritzation | -- | -- | $1.4M | $2.8M | $3.5M | |
Stock-Based Compensation | -- | -- | $30M | $29.4M | $32.6M | |
Change in Accounts Receivable | -- | -- | $1.6M | -$26M | -$202.1M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -$31.2M | $470.6M | $185.2M | |
Capital Expenditures | -- | -- | $31.6M | $4.5M | $2.4M | |
Cash Acquisitions | -- | -- | -$109.2K | -$5.5M | -- | |
Cash From Investing | -- | -- | -$32.4M | -$10M | -$2.4M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | $5M | |
Long-Term Debt Repaid | -- | -- | -$10.8M | -- | -$5M | |
Repurchase of Common Stock | -- | -- | -$55M | -- | -- | |
Other Financing Activities | -- | -- | -- | -$7.2M | -- | |
Cash From Financing | -- | -- | $17.9M | $12.8M | $40.3M | |
Beginning Cash (CF) | -- | -- | $569.5M | $518.3M | $994.1M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -$45.8M | $473.4M | $223.1M | |
Ending Cash (CF) | -- | -- | $518.3M | $994.1M | $1.2B | |
Levered Free Cash Flow | -- | -- | -$62.8M | $466.1M | $182.8M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -$13.6M | $10.6M | |
Depreciation & Amoritzation | -- | -- | -- | $787.4K | $866K | |
Stock-Based Compensation | -- | -- | -- | $6.1M | $6.6M | |
Change in Accounts Receivable | -- | -- | -- | $1.5M | -$73.3M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | $58.7M | $38.4M | |
Capital Expenditures | -- | -- | -- | $1.1M | $460.8K | |
Cash Acquisitions | -- | -- | -- | -$4M | -- | |
Cash From Investing | -- | -- | -- | -$5.1M | -$460.8K | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | -- | -- | -- | |
Beginning Cash (CF) | -- | -- | -- | $932.1M | $1.2B | |
Foreign Exchange Rate Adjustment | -- | -- | -- | $8.4M | -$8.3M | |
Additions / Reductions | -- | -- | -- | $53.6M | $38M | |
Ending Cash (CF) | -- | -- | -- | $994.1M | $1.2B | |
Levered Free Cash Flow | -- | -- | -- | $57.6M | $38M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -$9.8M | -- | |
Depreciation & Amoritzation | -- | -- | -- | $3.1M | -- | |
Stock-Based Compensation | -- | -- | $8.9M | $32.6M | $20.5M | |
Change in Accounts Receivable | -- | -- | -- | -$37M | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | $351M | -- | |
Capital Expenditures | -- | -- | $1M | $4.2M | $1.7M | |
Cash Acquisitions | -- | -- | -$1.5M | -$4M | -- | |
Cash From Investing | -- | -- | -- | -$8.2M | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | -- | $53.2M | -- | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | $396M | -- | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -- | -- | $346.8M | -- |
Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | $5.8M | -$23.2M | -- | |
Depreciation & Amoritzation | -- | -- | $2.8M | $3.5M | -- | |
Stock-Based Compensation | -- | -- | $29.4M | $32.6M | -- | |
Change in Accounts Receivable | -- | -- | -$26M | -$202.1M | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | $470.6M | $185.2M | -- | |
Capital Expenditures | -- | -- | $4.5M | $2.4M | -- | |
Cash Acquisitions | -- | -- | -$5.5M | -- | -- | |
Cash From Investing | -- | -- | -$10M | -$2.4M | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -$7.2M | -- | -- | |
Cash From Financing | -- | -- | $12.8M | $40.3M | -- | |
Beginning Cash (CF) | -- | -- | $2.9B | $4.3B | -- | |
Foreign Exchange Rate Adjustment | -- | -- | $2.5M | -$7.3M | -- | |
Additions / Reductions | -- | -- | $473.4M | $223.1M | -- | |
Ending Cash (CF) | -- | -- | $3.3B | $4.5B | -- | |
Levered Free Cash Flow | -- | -- | $466.1M | $182.8M | -- |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.